Target intelligence / Profile preview

Poly-rich RNA elements (PREs)

Target
PREs
Molecular classification
RNA regulatory element, 3' Untranslated Region (3' UTR) element, Non-coding RNA motif
01

Overview

Poly-rich RNA elements (PREs) are regulatory sequences found within the 3' untranslated regions (UTRs) of messenger RNAs (mRNAs) that consist of repetitive or enriched sequences of a single nucleotide, most commonly adenosine (A) or uridine (U) (Choi et al., 2020). These elements, which include AU-rich elements (AREs) and GU-rich elements (GREs), serve as critical binding sites for various RNA-binding proteins (RBPs) that control the stability, localization, and translation efficiency of the host mRNA (Garcia-Maurino et al., 2017). In many diseases, such as cancer and chronic inflammation, the dysregulation of PRE-mediated mRNA decay leads to the over-stabilization and overexpression of potent oncogenes and pro-inflammatory cytokines like TNF-alpha and MYC (Choi et al., 2020). Consequently, PREs have emerged as attractive therapeutic targets for small molecules and antisense oligonucleotides (ASOs) designed to either displace pathological RBPs or recruit nucleases to selectively degrade disease-associated transcripts (Disney et al., 2018). Recent advances in RNA-targeted drug discovery, including the development of Ribonuclease Targeting Chimeras (RIBOTACs), have demonstrated the feasibility of modulating gene expression by directly binding to these poly-rich motifs (Choi et al., 2020).

Other names
AU-rich elements (AREs)GU-rich elements (GREs)U-rich elementsC-rich elementsPoly-pyrimidine tracts3' UTR regulatory elementsPoly-rich elements (PREs)
02

Mechanism of action

Small molecules or ASOs bind to the poly-rich sequences to displace RNA-binding proteins (RBPs), recruit nucleases for targeted degradation (e.g., via RIBOTACs), or modulate mRNA stability and translation efficiency by altering the transcript's half-life.

03

Biological functions

mRNA stability regulationTranslation regulationmRNA decaymRNA localizationmRNA processing
04

Disease associations

CancerInflammationNeurodegenerative diseaseViral infection
05

Safety considerations

Off-target effects due to sequence similarity across the transcriptomePotential for global disruption of mRNA decay pathwaysToxicity from non-specific RNA bindingDifficulty in achieving high affinity for unstructured RNA regions
06

Interacting drugs

Small molecule RNA ligands

2 more in the full profile.

07

Biomarkers

mRNA expression levelsProtein expression levelsRBP-RNA occupancy (CLIP-seq)mRNA half-life

Beyond the preview

Go deeper on Poly-rich RNA elements (PREs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly-rich RNA elements (PREs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call